CME CME Group

Q3 2025 10-Q

Filed: Oct 24, 2025Period ending Sep 30, 2025

Financials

Security & Commodity Brokers, Dealers, Exchanges & ServicesSEC EDGAR

CME Group (CME) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 24, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue $1,537.6M Q3 2025, down 3% YoY from $1,584.4M Q3 2024
• Operating margin 63.3% Q3 2025 vs 64.6% YoY, net income $908.0M vs $912.8M, EPS $2.49 stable YoY

+3 more insights

Risk Factors

• No material changes in risk factors from 2024 10-K disclosed in this 10-Q
• Market volatility risk remains significant due to changing economic conditions affecting trading volumes

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.5B

▼ -3.0% YoY▼ -9.1% QoQ

Net Income

$897M

▼ -0.5% YoY▼ -11.4% QoQ

Net Margin

58.3%

▲ +143bp YoY▼ -151bp QoQ

Source: XBRL data from CME Group Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on CME Group

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.